#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	402	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1061	20.2	0	.	p	.	0	K29T	NONSYN	85	87	AAG	293	295	ACG	22;23;23	A;C;G	22;23;23	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	260	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	164	18.9	0	.	n	.	0	T879G	SNP	879	879	T	44	44	G	4	G	4	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	260	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	164	18.9	0	.	n	.	0	G880A	SNP	880	880	G	45	45	A	4	A	4	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	260	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	164	18.9	0	.	n	.	0	A888G	SNP	888	888	A	53	53	G	8	G	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	260	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	164	18.9	0	.	n	.	0	C897G	SNP	897	897	C	62	62	G	13	G	13	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	260	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	164	18.9	0	.	n	.	0	T898C	SNP	898	898	T	63	63	C	13	C	13	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	260	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	164	18.9	0	.	n	.	0	G906T	SNP	906	906	G	71	71	T	16	T	16	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	260	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	164	18.9	0	.	n	.	0	G908A	SNP	908	908	G	73	73	A	17	A	17	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	260	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	164	18.9	0	.	n	.	0	A918T	SNP	918	918	A	83	83	T	18	T	18	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	260	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	164	18.9	0	.	n	.	0	A943G	SNP	943	943	A	108	108	G	42	G	42	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	260	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	164	18.9	0	.	n	.	0	G991T	SNP	991	991	G	156	156	T	30	T	30	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1492	Escherichia_coli_EF_Tu	1230	1211	99.17	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1429	51.0	1	SNP	p	R234F	1	.	.	700	702	TTC	918	920	TTC	42;42;43	T;T;C	41;42;43	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1492	Escherichia_coli_EF_Tu	1230	1211	99.17	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1429	51.0	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1218	1220	CGT	72;71;70	C;G;T	72;71;70	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1492	Escherichia_coli_EF_Tu	1230	1211	99.17	Escherichia_coli_EF_Tu.l6.c30.ctg.1	1429	51.0	0	HET	.	.	.	C261T	.	261	261	C	479	479	C	48	C,T	29,17	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1492	Escherichia_coli_EF_Tu	1230	72	100.0	Escherichia_coli_EF_Tu.l6.c30.ctg.2	223	9.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1492	Escherichia_coli_EF_Tu	1230	136	99.26	Escherichia_coli_EF_Tu.l6.c30.ctg.3	310	2.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	626	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1863	18.0	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1569	1571	AAA	6;6;7	A;A;A	6;6;7	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	696	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l6.c4.ctg.1	1772	20.9	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1233	1235	GAA	29;29;30	G;A;A	29;29;30	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	176	H_NS	414	414	99.03	H_NS.l6.c4.ctg.1	858	10.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	89	G	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	93	T	72	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	123	G	121	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	113	C	113	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	99	C	98	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	90	T	90	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	86	C	86	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	80	C	79	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	91	A	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	93	A	93	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	95	A	95	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	97	T	97	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	99	C	98	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	91	C	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	87	A	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	80	G	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	80	C	79	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	88	T,A	85,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	106	G	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	110	G	109	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	112	T	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	114	T	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	113	G	113	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	81	C	79	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	72	A	71	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	43	C	42	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	40	C	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	9	A	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	9	A	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	7	G	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	19	C	19	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	46	T	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	52	G	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	44	T	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	91	C	91	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2060	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.3	532	97.8	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	77	C,T	29,26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	636	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1466	23.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	204	206	CGT	14;17;15	C;G;T	13;17;15	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	636	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1466	23.0	0	.	p	.	0	V30I	NONSYN	88	90	GTC	288	290	ATC	17;18;17	A;T;C	17;18;17	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	636	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1466	23.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1047	1049	GGC	26;23;22	G;G;C	26;23;22	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	788	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2018	20.8	0	.	p	.	0	R8S	NONSYN	22	24	AGA	236	238	AGC	4;4;4	A;G;C	4;4;4	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	788	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2018	20.8	0	.	p	.	0	I142L	NONSYN	424	426	ATA	638	640	CTA	22;22;20	C;T;A	22;22;20	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	788	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2018	20.8	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1157	1159	CAA	33;32;32	C;A;A	33;32;32	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	788	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2018	20.8	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1256	1258	GGT	26;26;27	G;G;T	26;26;27	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	788	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2018	20.8	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1826	1828	GTT	16;16;16	G;T;T	16;16;16	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	394	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1487	13.8	0	.	p	.	0	A125E	NONSYN	373	375	GCA	621	623	GAA	19;19;17	G;A;A	19;19;17	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	394	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1487	13.8	0	.	p	.	0	M185T	NONSYN	553	555	ATG	801	803	ACC	8;7;7	A;C;C	8;7;7	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	394	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1487	13.8	0	.	p	.	0	S225T	NONSYN	673	675	TCC	921	923	ACT	15;15;15	A;C;T	15;15;15	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	394	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1487	13.8	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1311	1313	ATC	7;8;8	A;T;C	7;7;8	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	516	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1491	18.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	0	62	TEM_1+	858	170	100.0	TEM_1+.l15.c4.ctg.1	170	5.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.;TEM-124
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	0	62	TEM_1+	858	99	100.0	TEM_1+.l15.c4.ctg.2	100	3.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.;TEM-124
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	476	aad-	789	789	100.0	aad-.l15.c4.ctg.1	1244	20.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1476	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3517	22.5	0	.	p	.	0	T85I	NONSYN	253	255	ACC	442	444	ATC	25;24;24	A;T;C	25;24;24	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1476	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3517	22.5	0	.	p	.	0	V416I	NONSYN	1246	1248	GTC	1435	1437	ATC	17;17;16	A;T;C	17;16;15	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1476	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3517	22.5	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2155	2157	AAG	10;10;10	A;A;G	10;10;10	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	626	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1594	20.9	0	.	p	.	0	A22V	NONSYN	64	66	GCC	245	247	GTC	5;7;8	G;T;C	5;7;8	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	626	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1594	20.9	0	.	p	.	0	S269C	NONSYN	805	807	AGC	986	988	TGC	31;30;30	T;G;C	31;30;30	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1286	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2794	24.2	0	.	p	.	0	S46trunc	TRUNC	136	136	T	166	166	T	12	T	12	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1286	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2794	24.2	0	.	p	.	0	G148D	NONSYN	442	444	GGC	472	474	GAC	24;25;26	G;A;C	24;24;25	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1286	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2794	24.2	0	.	p	.	0	F240L	NONSYN	718	720	TTT	748	750	TTA	15;14;15	T;T;A	15;14;15	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1286	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2794	24.2	0	.	p	.	0	D301N	NONSYN	901	903	GAT	931	933	AAT	17;17;17	A;A;T	17;17;17	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1286	acrF	3105	2598	98.04	acrF.l15.c17.ctg.1	2794	24.2	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1718	1718	T	28	T	28	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	320	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1066	16.0	1	SNP	p	R45C	0	.	.	133	135	CGC	347	349	CGC	24;20;21	C;G;C	24;20;21	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	310	acrS	663	663	98.64	acrS.l6.c4.ctg.1	1070	15.4	0	.	p	.	0	L34F	NONSYN	100	102	CTC	338	340	TTC	20;20;21	T;T;C	20;20;21	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	310	acrS	663	663	98.64	acrS.l6.c4.ctg.1	1070	15.4	0	.	p	.	0	E122G	NONSYN	364	366	GAG	602	604	GGG	19;19;19	G;G;G	19;19;19	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	374	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1156	17.2	0	.	p	.	0	V136L	NONSYN	406	408	GTT	609	611	CTT	28;29;29	C;T;T	28;29;29	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1492	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3082	25.8	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2118	2120	GCA	41;41;45	G;C;A	41;41;45	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1492	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3082	25.8	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2379	2381	ACC	31;31;32	A;C;C	29;31;32	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1492	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3082	25.8	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2688	2690	GCC	15;15;17	G;C;C	15;15;17	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	768	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2283	17.6	0	.	p	.	0	G37A	NONSYN	109	111	GGT	167	169	GCT	2;2;3	G;C;T	2;2;3	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	768	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2283	17.6	0	.	p	.	0	D77E	NONSYN	229	231	GAT	287	289	GAG	2;2;2	G;A;G	2;2;2	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	768	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2283	17.6	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	323	325	TGC	6;6;5	T;G;C	6;6;5	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	768	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2283	17.6	0	.	p	.	0	I150V	NONSYN	448	450	ATT	506	508	GTT	13;14;14	G;T;T	13;14;14	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	768	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2283	17.6	0	.	p	.	0	R200H	NONSYN	598	600	CGC	656	658	CAC	17;17;17	C;A;C	17;17;17	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	768	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2283	17.6	0	.	p	.	0	T295M	NONSYN	883	885	ACG	941	943	ATG	15;15;18	A;T;G	15;14;17	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	768	arnA_1	1983	1983	98.29	arnA_1.l6.c4.ctg.1	2283	17.6	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1937	1939	CGC	12;12;12	C;G;C	11;12;12	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	320	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1067	15.4	0	.	p	.	0	S221T	NONSYN	661	663	AGC	877	879	ACC	13;12;12	A;C;C	13;12;12	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	320	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1067	15.4	0	.	p	.	0	P225S	NONSYN	673	675	CCG	889	891	TCG	14;15;14	T;C;G	14;15;14	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	334	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1147	15.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	558	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1617	18.0	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1329	1331	AAA	9;9;9	A;A;A	8;9;9	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	558	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1617	18.0	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1341	1343	GAG	8;9;9	G;A;G	8;9;9	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	558	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1617	18.0	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1347	1349	CAC	9;8;7	C;A;C	9;8;7	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	558	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1617	18.0	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1401	1403	GAG	18;18;18	G;A;G	18;18;18	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	674	cpxA	1374	1374	98.91	cpxA.l15.c17.ctg.1	1840	19.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	456	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1085	22.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	448	cysB	975	975	99.28	cysB.l6.c30.ctg.1	1390	17.2	0	.	p	.	0	A146T	NONSYN	436	438	GCT	634	636	ACT	24;24;24	A;C;T	24;24;24	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	274	dfrA1_1	474	474	100.0	dfrA1_1.l15.c4.ctg.1	908	16.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1;dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	596	emrA	1173	1173	98.29	emrA.l6.c4.ctg.1	1542	20.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	840	842	GTC	35;35;34	G,T;T;C	32,1;33;32	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	896	emrB	1539	1539	99.74	emrB.l6.c4.ctg.1	2069	23.2	0	.	p	.	0	E197K	NONSYN	589	591	GAA	865	867	AAA	27;27;28	A;A;A	27;27;28	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	560	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1645	18.1	0	.	p	.	0	G209S	NONSYN	625	627	GGC	889	891	AGC	16;16;16	A,C;G;C	15,1;16;16	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	20	emrE_1	333	94	96.81	emrE_1.l15.c4.ctg.1	94	5.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	404	emrK	1056	1056	98.2	emrK.l15.c17.ctg.1	1263	16.1	0	.	p	.	0	K176R	NONSYN	526	528	AAG	691	693	AGG	8;8;8	A;G;G	8;8;8	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	404	emrK	1056	1056	98.2	emrK.l15.c17.ctg.1	1263	16.1	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1081	1083	GAC	11;11;11	G;A;C	11;11;11	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	332	emrR	531	531	100.0	emrR.l15.c17.ctg.1	924	19.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	636	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1907	17.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	282	evgA	615	615	99.19	evgA.l15.c17.ctg.1	781	17.4	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	292	294	CTG	22;23;23	C;T;G	22;23;23	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	T38I	NONSYN	112	114	ACA	174	176	ATA	3;3;3	A;T;A	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	L42V	NONSYN	124	126	CTA	186	188	GTA	5;6;6	G;T;A	5;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	A93T	NONSYN	277	279	GCG	339	341	ACG	13;13;12	A;C;G	13;13;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	A114E	NONSYN	340	342	GCA	402	404	GAA	17;18;18	G;A;A	16;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	T127A	NONSYN	379	381	ACT	441	443	GCT	21;19;18	G;C;T	21;19;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	N133D	NONSYN	397	399	AAT	459	461	GAT	20;18;19	G;A;T	20;18;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	546	548	TCA	12;12;13	T;C;A	12;12;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	675	677	CAG	7;8;9	C;A;G	7;8;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	I251V	NONSYN	751	753	ATT	813	815	GTT	7;7;7	G;T;T	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	N303D	NONSYN	907	909	AAT	969	971	GAT	3;3;3	G;A;T	3;3;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1137	1139	AAT	4;4;4	A;A;T	4;4;4	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1158	1160	TTA	3;2;2	T;T;A	3;2;2	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1359	1361	AAA	12;11;10	A;A;A	12;11;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2094	2096	CAT	19;19;17	C;A;T	19;19;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2148	2150	CAT	15;15;15	C;A;T	15;15;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2166	2168	AGA	16;16;16	A;G;A	16;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2181	2183	AAT	14;14;14	A;A;T	14;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2328	2330	TCC	9;10;11	T;C;C	9;10;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2493	2495	ATT	7;7;9	A;T;T	7;7;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2514	2516	GAT	8;8;8	G;A;T	8;8;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2628	2630	GTT	29;30;30	G;T;T	29;30;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1250	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	3839	17.3	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	2913	2915	CAC	18;19;19	C;A;C	18;19;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	440	folP_1	849	849	99.29	folP_1.l6.c17.ctg.1	1271	18.6	1	SNP	p	P64L	0	.	.	190	192	CCA	394	396	CCA	36;35;36	C;C;A	36;35;34	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	440	folP_1	849	849	99.29	folP_1.l6.c17.ctg.1	1271	18.6	1	SNP	p	P64A	0	.	.	190	192	CCA	394	396	CCA	36;35;36	C;C;A	36;35;34	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	440	folP_1	849	849	99.29	folP_1.l6.c17.ctg.1	1271	18.6	1	SNP	p	P64S	0	.	.	190	192	CCA	394	396	CCA	36;35;36	C;C;A	36;35;34	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	440	folP_1	849	849	99.29	folP_1.l6.c17.ctg.1	1271	18.6	1	SNP	p	P64H	0	.	.	190	192	CCA	394	396	CCA	36;35;36	C;C;A	36;35;34	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	440	folP_1	849	849	99.29	folP_1.l6.c17.ctg.1	1271	18.6	1	SNP	p	P64R	0	.	.	190	192	CCA	394	396	CCA	36;35;36	C;C;A	36;35;34	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	248	gadE	528	528	100.0	gadE.l15.c30.ctg.1	987	13.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	80	gadW	729	231	96.1	gadW.l15.c17.ctg.1	302	8.9	0	.	p	.	0	S234A	NONSYN	700	702	TCG	202	204	GCG	6;6;6	G;C;G	6;6;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	266	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1020	13.7	0	.	p	.	0	F53L	NONSYN	157	159	TTC	313	315	TTA	17;17;15	T;T;A	17;17;15	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	266	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1020	13.7	0	.	p	.	0	V79I	NONSYN	235	237	GTT	391	393	ATT	8;9;9	A;T;T	8;9;9	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	266	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1020	13.7	0	.	p	.	0	R246G	NONSYN	736	738	AGA	892	894	GGA	13;13;13	G;G;A	13;13;13	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	266	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1020	13.7	0	.	p	.	0	S248P	NONSYN	742	744	TCG	898	900	CCG	11;11;11	C;C;G	11;11;11	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1454	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3043	25.6	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2248	2250	GAA	32;33;33	G;A;A	32;33;33	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1454	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3043	25.6	1	SNP	p	S83W	0	.	.	247	249	TCG	463	465	TCG	20;20;21	T;C;G	19;20;19	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1454	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3043	25.6	1	SNP	p	S83I	0	.	.	247	249	TCG	463	465	TCG	20;20;21	T;C;G	19;20;19	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1454	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3043	25.6	1	SNP	p	S83L	0	.	.	247	249	TCG	463	465	TCG	20;20;21	T;C;G	19;20;19	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1454	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3043	25.6	1	SNP	p	D87H	0	.	.	259	261	GAC	475	477	GAC	21;20;20	G;A;C	21;18;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1454	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3043	25.6	1	SNP	p	D87V	0	.	.	259	261	GAC	475	477	GAC	21;20;20	G;A;C	21;18;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1454	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3043	25.6	1	SNP	p	D87N	0	.	.	259	261	GAC	475	477	GAC	21;20;20	G;A;C	21;18;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1454	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3043	25.6	1	SNP	p	D87Y	0	.	.	259	261	GAC	475	477	GAC	21;20;20	G;A;C	21;18;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1454	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3043	25.6	1	SNP	p	D87G	0	.	.	259	261	GAC	475	477	GAC	21;20;20	G;A;C	21;18;20	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1150	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2702	22.0	1	SNP	p	R136I	0	.	.	406	408	CGC	633	635	CGC	16;16;15	C;G;C,T	16;16;14,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1150	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2702	22.0	1	SNP	p	R136L	0	.	.	406	408	CGC	633	635	CGC	16;16;15	C;G;C,T	16;16;14,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1150	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2702	22.0	1	SNP	p	R136E	0	.	.	406	408	CGC	633	635	CGC	16;16;15	C;G;C,T	16;16;14,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1150	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2702	22.0	1	SNP	p	R136S	0	.	.	406	408	CGC	633	635	CGC	16;16;15	C;G;C,T	16;16;14,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1150	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2702	22.0	1	SNP	p	R136C	0	.	.	406	408	CGC	633	635	CGC	16;16;15	C;G;C,T	16;16;14,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1150	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2702	22.0	1	SNP	p	R136G	0	.	.	406	408	CGC	633	635	CGC	16;16;15	C;G;C,T	16;16;14,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1150	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2702	22.0	1	SNP	p	R136H	0	.	.	406	408	CGC	633	635	CGC	16;16;15	C;G;C,T	16;16;14,1	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	292	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1044	14.8	0	.	p	.	0	A72P	NONSYN	214	216	GCG	430	432	CCG	21;20;20	C;C;G,A	21;20;19,1	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	292	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1044	14.8	0	.	p	.	0	T123A	NONSYN	367	369	ACC	583	585	GCC	18;18;17	G;C;C	18;18;17	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	498	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1203	21.9	0	.	p	.	0	P9S	NONSYN	25	27	CCA	161	163	TCA	16;16;17	T;C;A	16;16;17	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	196	marA	384	384	99.74	marA.l15.c4.ctg.1	760	13.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	514	516	AGC	12;12;12	A;G;C	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	616	618	CAT	4;3;3	C;A;T	4;3;3	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	V45E	0	.	.	133	135	GTG	340	342	GTG	19;19;19	G;T;G	19;19;19	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	I49S	0	.	.	145	147	ATC	352	354	ATC	23;23;23	A;T;C	23;23;23	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	A70T	0	.	.	208	210	GCA	415	417	GCA	13;13;12	G;C;A	13;13;12	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	R73C	0	.	.	217	219	CGT	424	426	CGT	11;11;11	C;G;T	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	R73S	0	.	.	217	219	CGT	424	426	CGT	11;11;11	C;G;T	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	R77L	0	.	.	229	231	CGC	436	438	CGC	10;10;11	C;G;C	10;10;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	R77C	0	.	.	229	231	CGC	436	438	CGC	10;10;11	C;G;C	10;10;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	L78M	0	.	.	232	234	CTG	439	441	CTG	11;10;10	C;T;G	11;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	R94S	0	.	.	280	282	CGC	487	489	CGC	8;8;8	C;G;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	R94H	0	.	.	280	282	CGC	487	489	CGC	8;8;8	C;G;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	140	marR	435	422	97.63	marR.l15.c30.ctg.1	629	11.5	1	SNP	p	V96E	0	.	.	286	288	GTA	493	495	GTA	8;9;9	G;T;A	8;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	406	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1348	15.4	0	.	p	.	0	S7F	NONSYN	19	21	TCC	19	21	TTC	2;2;2	T;T;C	2;2;2	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	406	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1348	15.4	0	.	p	.	0	R36I	NONSYN	106	108	AGG	106	108	ATC	11;9;8	A;T;C	11;9;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	406	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1348	15.4	0	.	p	.	0	E42A	NONSYN	124	126	GAA	124	126	GCC	2;2;2	G;C;C	2;2;2	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	406	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1348	15.4	0	.	p	.	0	N43V	NONSYN	127	129	AAT	127	129	GTG	2;2;2	G;T;G	2;2;2	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	406	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1348	15.4	0	.	p	.	0	E52D	NONSYN	154	156	GAG	154	156	GAT	7;7;7	G;A;T	7;7;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	406	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1348	15.4	0	.	p	.	0	N59T	NONSYN	175	177	AAC	175	177	ACC	9;9;8	A;C;C	9;9;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	406	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1348	15.4	0	.	p	.	0	I68L	NONSYN	202	204	ATA	202	204	TTA	9;8;7	T;T;A	9;8;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	406	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1348	15.4	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	343	345	CAG	16;16;16	C;A;G	16;16;16	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	406	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1348	15.4	0	.	p	.	0	D128A	NONSYN	382	384	GAC	382	384	GCC	18;17;17	G;C;C	18;17;17	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	406	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1348	15.4	0	.	p	.	0	S163A	NONSYN	487	489	TCG	487	489	GCG	13;13;15	G;C;G	12;13;15	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	406	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1348	15.4	0	.	p	.	0	L231V	NONSYN	691	693	CTT	691	693	GTT	15;15;16	G,T;T;T	9,1;15;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	406	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1348	15.4	0	.	p	.	0	R285fs	FSHIFT	853	853	C	853	853	C	15	C	14	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	460	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1705	14.4	0	.	p	.	0	V12trunc	TRUNC	34	34	G	288	288	G	25	G	25	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	460	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1705	14.4	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	345	347	CAG	11;12;12	C;A;G	11;11;12	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	460	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1705	14.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	495	497	ATC	16;15;15	A;T;C	16;15;15	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	460	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1705	14.4	0	.	p	.	0	I99M	NONSYN	295	297	ATA	543	545	ATG	9;9;10	A;T;G	9;9;10	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	460	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1705	14.4	0	.	p	.	0	A130T	NONSYN	388	390	GCC	636	638	ACC	19;19;19	A;C;C	19;19;19	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	460	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1705	14.4	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1017	1019	ACG	14;14;13	A;C;G	14;14;13	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1584	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3497	24.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1975	1977	ACC	34;34;33	A;C;C	34;34;33	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1584	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3497	24.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2368	2370	CAA	13;13;12	C;A;A	13;13;12	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1584	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3497	24.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2536	2538	ATT	17;15;14	A;T;T	17;15;14	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1584	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3497	24.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2620	2622	GTT	29;30;31	G;T;T	29;30;31	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1584	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3497	24.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2728	2730	GAG	14;15;15	G;A;G	14;15;15	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1584	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3497	24.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2956	2958	ATG	12;12;12	A;T;G	12;12;12	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1584	mdtB	3123	3123	98.98	mdtB.l6.c30.ctg.1	3497	24.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3091	3093	GAT	22;20;22	G;A;T	22;19;21	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1392	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3296	22.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	335	337	ATG	14;15;15	A;T;G	14;15;15	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1392	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3296	22.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	821	823	ATC	32;32;30	A;T;C	31;32;30	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1392	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3296	22.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3137	3139	CAC	4;4;4	C;A;C	4;4;4	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1392	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3296	22.4	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3140	3142	CTC	4;4;4	C;T;C	4;4;4	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	664	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1838	19.2	0	.	p	.	0	D3E	NONSYN	7	9	GAT	207	209	GAA	14;13;13	G;A;A	14;13;13	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	664	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1838	19.2	0	.	p	.	0	T226A	NONSYN	676	678	ACG	876	878	GCG	19;19;17	G;C;G	19;19;17	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	664	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1838	19.2	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1218	1220	ATC	17;18;18	A;T;C	16;17;18	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	664	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1838	19.2	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1521	1523	TTT	26;28;27	T;T;T	26;28;27	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	666	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1594	22.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1628	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3509	24.7	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1096	1098	ACC	24;24;24	A;C,A;C	24;21,2;23	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1628	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3509	24.7	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2338	2340	GAC	29;30;31	G;A;C	29;30;31	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	664	mdtG	1227	1047	99.33	mdtG.l15.c4.ctg.1	1446	20.1	0	.	p	.	0	V200I	NONSYN	598	600	GTC	609	611	ATC	27;27;28	A;T;C	27;27;28	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	664	mdtG	1227	177	99.44	mdtG.l15.c4.ctg.2	361	12.1	0	.	p	.	0	E5G	NONSYN	13	15	GAA	8	10	GGA	2;2;2	G;G;A	2;2;2	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	506	mdtH	1209	1209	98.18	mdtH.l15.c17.ctg.1	1255	19.7	0	.	p	.	0	G134C	NONSYN	400	402	GGT	411	413	TGT	25;25;25	T;G;T	25;25;25	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	506	mdtH	1209	1209	98.18	mdtH.l15.c17.ctg.1	1255	19.7	0	.	p	.	0	S324L	NONSYN	970	972	TCG	981	983	TTG	18;17;18	T;T;G	18;17;18	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	506	mdtH	1209	1209	98.18	mdtH.l15.c17.ctg.1	1255	19.7	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1191	1193	ACG	9;9;9	A;C;G	9;9;9	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	582	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1597	19.4	0	.	p	.	0	A185S	NONSYN	553	555	GCC	753	755	TCC	12;12;12	T;C;C	10;12;12	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	450	mdtN	1032	1032	98.06	mdtN.l6.c17.ctg.1	1425	16.7	0	.	p	.	0	V119I	NONSYN	355	357	GTT	545	547	ATT	16;16;16	A;T;T	16;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	976	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2318	22.3	0	.	p	.	0	V11M	NONSYN	31	33	GTG	130	132	ATG	15;15;18	A;T;G	15;15;18	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	976	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2318	22.3	0	.	p	.	0	T33I	NONSYN	97	99	ACC	196	198	ATC	22;20;19	A;T;C	20;20;19	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	976	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2318	22.3	0	.	p	.	0	C116R	NONSYN	346	348	TGC	445	447	CGC	26;26;26	C;G;C	26;25;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	976	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2318	22.3	0	.	p	.	0	N238S	NONSYN	712	714	AAC	811	813	AGC	27;25;25	A;G,T;C	27;24,1;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	976	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2318	22.3	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1012	1014	GTG	15;15;15	G;T;G	15;15;15	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	976	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2318	22.3	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1075	1077	AAC	9;8;7	A;A;C	9;8;7	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	976	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2318	22.3	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1120	1122	GTC	12;12;12	G;T;C	12;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	976	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2318	22.3	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1150	1152	ATA	20;19;20	A;T;A	20;18;20	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	976	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2318	22.3	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1258	1260	TCT	10;10;10	T;C;T	10;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	976	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2318	22.3	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1645	1647	GCG	22;23;23	G;C;G	22;23;23	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	976	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2318	22.3	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1858	1860	ATC	23;23;26	A;T;C	23;23;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	654	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1629	20.7	0	.	p	.	0	S129A	NONSYN	385	387	TCA	482	484	GCG	19;18;18	G;C;G	19;18;17	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	654	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1629	20.7	0	.	p	.	0	A187T	NONSYN	559	561	GCC	656	658	ACC	15;15;17	A;C;C	14;15;17	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	654	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1629	20.7	0	.	p	.	0	H211R	NONSYN	631	633	CAC	728	730	CGC	20;20;19	C;G;C	20;20;19	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	654	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1629	20.7	0	.	p	.	0	V250A	NONSYN	748	750	GTT	845	847	GCT	15;15;15	G;C;T	14;15;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	654	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1629	20.7	0	.	p	.	0	R278K	NONSYN	832	834	AGA	929	931	AAA	12;11;9	A;A;A	12;11;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	654	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1629	20.7	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	947	949	CGA	14;15;15	C;G;A	14;15;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	654	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1629	20.7	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1112	1114	GCC	18;19;19	G;C;C	18;19;19	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	654	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1629	20.7	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1124	1126	GAT	21;22;23	G;A;T	21;22;23	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	654	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1629	20.7	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1541	1543	GCT	6;6;6	G;C;T	6;6;6	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1600	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3837	22.2	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1492	1494	AAG	18;18;17	A;A;G	18;18;17	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1600	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3837	22.2	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2569	2571	CTG	27;27;27	C;T;G	27;27;27	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	19	82	mgrB	144	141	100.0	mgrB.l15.c30.ctg.1	156	14.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	940	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2190	22.9	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1073	1075	AAC	12;14;14	A;A;C	12;14;14	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	940	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2190	22.9	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1619	1621	ATA	27;28;29	A;T;A	27;27;29	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	756	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1695	23.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1337	1339	GAT	33;32;33	G;A;T	33;32;33	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	756	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1695	23.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1340	1342	CTG	33;33;32	C;T;G	33;33;31	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	222	nfsA	723	405	99.01	nfsA.l6.c30.ctg.1	862	13.5	0	.	p	.	0	R27C	NONSYN	79	81	CGT	301	303	TGT	22;22;21	T;G;T	22;22;21	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	222	nfsA	723	405	99.01	nfsA.l6.c30.ctg.1	862	13.5	0	.	p	.	0	I117T	NONSYN	349	351	ATC	571	573	ACC	17;17;17	A;C;C	17;17;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	222	nfsA	723	405	99.01	nfsA.l6.c30.ctg.1	862	13.5	1	SNP	p	R15C	0	.	.	43	45	CGC	265	267	CGC	26;26;26	C;G;C	26;26;25	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	222	nfsA	723	405	99.01	nfsA.l6.c30.ctg.1	862	13.5	1	SNP	p	S33R	0	.	.	97	99	AGC	319	321	AGC	23;22;22	A;G;C	23;22;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	222	nfsA	723	405	99.01	nfsA.l6.c30.ctg.1	862	13.5	1	SNP	p	G131D	0	.	.	391	393	GGC	613	615	GGC	19;18;17	G;G;C	19;18;17	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	576	ompF	1089	1089	99.91	ompF.l6.c17.ctg.1	1338	21.8	0	.	p	.	0	D312E	NONSYN	934	936	GAT	995	997	GAG	24;24;25	G;A;G	24;24;25	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	576	ompF	1089	1089	99.91	ompF.l6.c17.ctg.1	1338	21.8	1	SNP	p	G141E	0	.	.	421	423	GGT	482	484	GGT	27;28;28	G;G;T	26;26;27	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	576	ompF	1089	1089	99.91	ompF.l6.c17.ctg.1	1338	21.8	1	SNP	p	G141D	0	.	.	421	423	GGT	482	484	GGT	27;28;28	G;G;T	26;26;27	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	576	ompF	1089	1089	99.91	ompF.l6.c17.ctg.1	1338	21.8	1	SNP	p	R154A	0	.	.	460	462	CGT	521	523	CGT	21;22;22	C;G;T	21;22;21	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	576	ompF	1089	1089	99.91	ompF.l6.c17.ctg.1	1338	21.8	1	SNP	p	R154D	0	.	.	460	462	CGT	521	523	CGT	21;22;22	C;G;T	21;22;21	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1364	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2673	27.3	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1822	1824	GTG	27;27;27	G;T;G	26;27;26	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1364	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2673	27.3	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1849	1851	TCG	19;19;19	T;C;G	16;18;19	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1364	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2673	27.3	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2464	2466	AAC	23;23;22	A;A;C	23;23;22	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1364	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2673	27.3	1	SNP	p	A85T	0	.	.	253	255	GCG	478	480	GCG	26;26;26	G;C;G	26;25;26	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1364	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2673	27.3	1	SNP	p	D111H	0	.	.	331	333	GAT	556	558	GAT	23;22;22	G;A;T	23;22;22	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1364	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2673	27.3	1	SNP	p	S129P	0	.	.	385	387	TCC	610	612	TCC	36;36;38	T;C;C	32;36;38	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	523	756	parE_1	1893	1893	97.43	parE_1.l15.c30.ctg.1	1954	18.6	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1277	1279	AAC	21;21;22	A;A;C	21;21;22	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	523	756	parE_1	1893	1893	97.43	parE_1.l15.c30.ctg.1	1954	18.6	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1286	1288	GAT	23;22;22	G;A;T	23;22;22	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	523	756	parE_1	1893	138	98.55	parE_1.l15.c30.ctg.2	199	12.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	794	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1812	23.5	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	842	844	CAG	14;14;14	C;A;G	14;14;14	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	794	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1812	23.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1316	1318	GAT	40;38;36	G;A;T	40;38;35	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2284	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4412	27.6	1	SNP	p	V146F	0	.	.	436	438	GTT	617	619	GTT	28;29;29	G;T;T	28;29;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2284	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4412	27.6	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1718	1720	CAG	32;32;32	C;A;G	32;32;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2284	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4412	27.6	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1718	1720	CAG	32;32;32	C;A;G	32;32;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2284	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4412	27.6	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1757	1759	CAC	27;27;28	C;A;C	27;27;28	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2284	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4412	27.6	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1766	1768	CGT	24;24;23	C;G;T	24;24;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2284	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4412	27.6	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1766	1768	CGT	24;24;23	C;G;T	24;24;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2284	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4412	27.6	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1772	1774	TCC	23;22;24	T;C;C,A	23;22;23,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2284	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4412	27.6	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1778	1780	CTC	23;22;22	C;T;C	23;22;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2284	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4412	27.6	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1868	1870	ACC	30;30;30	A;C;C	30;30;30	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2284	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4412	27.6	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1871	1873	CCT	29;31;31	C;C;T	29;31;30	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2284	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4412	27.6	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2240	2242	CGT	32;32;30	C;G;T	31;31;30	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	.	n	.	0	A226G	SNP	226	226	A	379	379	G	205	G	205	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	1	SNP	n	A794T	0	.	.	794	794	A	947	947	A	174	A	172	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	1	SNP	n	A794G	0	.	.	794	794	A	947	947	A	174	A	172	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	1	SNP	n	G926C	0	.	.	926	926	G	1079	1079	G	180	G	179	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	1	SNP	n	G926A	0	.	.	926	926	G	1079	1079	G	180	G	179	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	1	SNP	n	G926T	0	.	.	926	926	G	1079	1079	G	180	G	179	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	1	SNP	n	A1519T	0	.	.	1519	1519	A	1672	1672	A	129	A	128	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	1	SNP	n	A1519C	0	.	.	1519	1519	A	1672	1672	A	129	A	128	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	1	SNP	n	A1519G	0	.	.	1519	1519	A	1672	1672	A	129	A	128	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	G1002A	.	1002	1002	G	1155	1155	G	201	G,A	133,68	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	G1006C	.	1006	1006	G	1159	1159	G	196	G,C	130,62	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	A79G	.	79	79	A	232	232	A	175	A,G	138,34	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	C719T	.	719	719	C	872	872	C	158	C,T	96,62	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	T273A	.	273	273	T	426	426	T	195	T,A	141,52	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	T1010C	.	1010	1010	T	1163	1163	T	198	T,C	133,60	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	C1038T	.	1038	1038	C	1191	1191	C	196	C,T	120,75	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	C183T	.	183	183	C	336	336	C	152	C,T	96,54	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	T90C	.	90	90	T	243	243	T	175	T,C	132,40	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	A250T	.	250	250	A	403	403	A	204	A,T	160,42	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	G474A,T	.	474	474	G	627	627	G	209	G,A,T	159,48,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	A253T	.	253	253	A	406	406	A	199	A,T	154,42	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6060	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1709	178.2	0	HET	.	.	.	C194T	.	194	194	C	347	347	C	154	C,T	120,31	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	356	sat_1	525	525	100.0	sat_1.l6.c4.ctg.1	833	21.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	286	soxR	465	465	100.0	soxR.l15.c4.ctg.1	861	17.7	1	SNP	p	R20H	0	.	.	58	60	CGC	218	220	CGC	26;27;28	C;G;C	26;27;28	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	286	soxR	465	465	100.0	soxR.l15.c4.ctg.1	861	17.7	1	SNP	p	G121D	0	.	.	361	363	GGT	521	523	GGT	16;16;19	G;G;T	16;16;19	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	214	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	746	15.3	1	SNP	p	A12S	0	.	.	34	36	GCA	256	258	GCA	26;25;25	G;C;A	26;24;25	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	822	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1885	23.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
